Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleINVITED PERSPECTIVE

The Future of Nuclear Medicine in the United States

George M. Segall, Maria Watts and Kirk A. Frey
Journal of Nuclear Medicine September 2023, 64 (9) 1354-1355; DOI: https://doi.org/10.2967/jnumed.123.265674
George M. Segall
American Board of Nuclear Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Watts
American Board of Nuclear Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirk A. Frey
American Board of Nuclear Medicine, St. Louis, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

The American Board of Nuclear Medicine (ABNM) has certified 6,031 physicians in nuclear medicine (NM) from 1972 to 2022, of whom 3,733 are still active, meaning they are not retired or deceased and have maintained their ABNM certification (Fig. 1). This number has not changed significantly since 2015, indicating that the workforce is stable despite the decrease in the number of Accreditation Council for Graduate Medical Education (ACGME)–accredited NM programs from 43 to 36 during the same period.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Active, retired, and deceased ABNM diplomates.

There has been a marked decrease in the total number of residents in ACGME-accredited NM programs since 2009, when the number was 166 (Fig. 2). The decrease initially was due to an increase in the length of training from 2 to 3 y required by the ACGME in 2007, but this change could not explain the continuing decline until 2016, when the number reached a nadir of 74 before stabilizing. There are currently a total of 80 NM residents, which does not account for additional trainees in other pathways.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Number of NM programs and trainees.

There was also a decrease in the number of physicians certified by the ABNM each year, but the decrease started later, and the percentage decrease was smaller (Fig. 3). More recently, there has been a significant increase in the number of diplomates certified by the ABNM without a significant change in the total number of NM residents. The reason is an increasing number of physicians in dual NM and diagnostic radiology (DR) training pathways that shorten NM training from 3 y to a minimum of 16 mo, as well as an increasing number of physicians who are designated by their training institutions as DR residents or NM fellows in non–ACGME-accredited positions during their NM training. For example, 20% of ABNM-certified physicians from 2018 to 2022 completed 16 mo of NM training during 4 y of DR training, equal to the percentage of physicians who completed 3 y of NM training.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Number of ACGME NM residents per academic year vs. ABNM diplomates certified each year.

Diagnostic radiologists who are also certified by the ABNM have always been a majority of physicians practicing NM. The average percentage over the past 20 y has been 54%, but the percentage over the past 5 y has increased to 70% (Fig. 4). The training pathways of candidates for the 2022 ABNM certification are shown in Figure 5. Twenty-eight percent of candidates completed 3 y of NM training, with an additional 7% having NM training outside the United States and Canada. Sixty-five percent of candidates had DR training, including 27% with 4 y of DR training plus an additional 1 y of NM or nuclear radiology training, and 26% with 16 mo of NM training during 4 y of DR training. Candidates with DR training had a pass rate of 96% on the 2022 ABNM certification examination, indicating a high degree of competence.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Annual number and average percentage (20 y/last 5 y) of ABNM diplomates certified by other American Board of Medical Specialties member boards. ABR = American Board of Radiology.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Training pathways of candidates for 2022 ABNM certification examination. ABR alt = American Board of Radiology alternative.

The average percentage of NM physicians certified in medical specialties other than radiology has decreased from 10% to 5% over the past 20 y. The ABNM and the American Board of Internal Medicine have a 4-y combined training pathway leading to certification in both specialties, but few physicians have used this pathway. In the future, there may be increased interest in this pathway because of the importance of NM in oncology, particularly theranostics.

There are opportunities and challenges in training the future NM workforce. Presently, there is an overreliance on international medical graduates. In 2011, international medical graduates accounted for 59% of NM residents. In 2021, that percentage increased to 82%. Thirty-three percent of the 36 ACGME-accredited NM programs did not have any medical students from their affiliated universities matriculate into any NM program in the United States, on the basis of candidates taking the ABNM certification examination in the past 5 y (2018–2022). Another 36% had only 1 student matriculate into a NM program during the same period. Recruiting medical students at the universities that have ACGME-accredited NM programs is an important opportunity.

The impact of dual training in NM and DR on the number of physicians who choose an academic career and do NM research is unknown. On the basis of self-reported information in 2020, 43% of ABNM physicians answered that they were in academic practice, 46% answered that they were in private practice, and 11% answered “other” (1). The percentage of NM physicians in academic practice seems robust, but the ABNM does not have any information about the amount of research being performed. The ACGME and the ABNM currently allow up to 6 mo of elective or research time during 3 y of training. There is an opportunity to engage the ACGME and other stakeholders to develop models that promote research during training and encourage residents to pursue academic careers (2).

Change is inevitable. NM will continue to evolve as a specialty. The ABNM will work with all stakeholders to meet the challenges and take advantage of the opportunities to ensure a bright future.

Footnotes

  • Published online Aug. 10, 2023.

  • © 2023 by the Society of Nuclear Medicine and Molecular Imaging.

REFERENCES

  1. 1.↵
    1. Segall GM
    . ABNM diplomate profile. J Nucl Med. 2020;61(9):22N.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Segall GM
    . ABNM support for research during training. J Nucl Med. 2018;59(6):16N.
    OpenUrlFREE Full Text
  • Received for publication May 4, 2023.
  • Revision received July 17, 2023.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (9)
Journal of Nuclear Medicine
Vol. 64, Issue 9
September 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Future of Nuclear Medicine in the United States
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The Future of Nuclear Medicine in the United States
George M. Segall, Maria Watts, Kirk A. Frey
Journal of Nuclear Medicine Sep 2023, 64 (9) 1354-1355; DOI: 10.2967/jnumed.123.265674

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Future of Nuclear Medicine in the United States
George M. Segall, Maria Watts, Kirk A. Frey
Journal of Nuclear Medicine Sep 2023, 64 (9) 1354-1355; DOI: 10.2967/jnumed.123.265674
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Future of Nuclear Medicine
  • Google Scholar

More in this TOC Section

  • Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions
  • Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine
  • Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
Show more INVITED PERSPECTIVE

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire